Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

was awarded to the King Faisal Specialist Hospital & Research Centre for revolutionising organ transplantation through ...

In what could be seen as a bellwether for the pharmaceutical industry's sweeping shift toward localised manufacturing—spurred ...

Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG (NOVN – Research Report) on April 24 and set a price target of ...

European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S.

As part of this bold initiative, Novartis will construct and expand ten facilities, including seven entirely new sites. The project is expected to generate nearly 1,000 new jobs directly within ...

The U.S. pays the most for drugs in the world, often nearly three times that of other developed nations. "European price ...

Novartis Trading Up 1.0 % Shares of Novartis stock opened at $110.69 on Friday. Novartis has a fifty-two week low of $94.72 and a fifty-two week high of $120.92. The company has a debt-to-equity ...